Document is current

Any future updates will be listed below

The Evolution of Turbocharged Cancer Therapeutics - How Regulatory Flexibility has Driven Accelerated Cancer Biologics Approvals in the United States (1993–2023)

Crossref DOI link: https://doi.org/10.1007/s12247-025-10059-8

Published Online: 2025-07-26

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark